Cleared Traditional

K113206 - NANOBLUTM 500

K113206 is an FDA 510(k) clearance for NANOBLUTM 500, manufactured by Draeger Medical Systems, Inc.. The device is a Class 2 General Hospital device with product code LBI cleared through the Traditional 510(k) pathway after a 108-day FDA review.

K113206 · Draeger Medical Systems, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2012
Decision
108d
Days
Class 2
Risk

K113206 is an FDA 510(k) clearance for the NANOBLUTM 500. Classified as Unit, Neonatal Phototherapy (product code LBI), Class II - Special Controls.

Submitted by Draeger Medical Systems, Inc. (Telford, US). The FDA issued a Cleared decision on February 17, 2012 after a review of 108 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5700 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Draeger Medical Systems, Inc. devices

FDA 510(k) Submission Details - K113206

510(k) Number K113206 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 01, 2011
Decision Date February 17, 2012
Days to Decision 108 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
21d faster than avg
Panel avg: 129d · This submission: 108d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LBI Device Classification - Class 2, Special Controls

Product Code LBI Unit, Neonatal Phototherapy
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5700
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LBI Unit, Neonatal Phototherapy

All 54
Devices cleared under the same product code (LBI) and FDA review panel - the closest regulatory comparables to K113206.
GIRAFFE BLUE SPOT PT LITE
K120820 · Lumitex, Inc. · Jun 2012
LULLABY LED PHOTTHERAPY SYSTEM
K120168 · Wipro GE Healthcare Private, Ltd. · May 2012
BILI-THERAPY PAD TYPE
K111547 · Atom Medical Corporation · Apr 2012
BRIGHT EMBRACE MODEL SBL60
K110550 · Physician Engineered Products, Inc. · Feb 2012
MEDILED MINI
K103735 · Medix I.C.S.A. · Aug 2011
NEOBLUE BLANKET LED PHOTOTHERAPY SYSTEM
K103589 · Natus Medical Incorporated · May 2011